NCT04364256View on ClinicalTrials.gov

Muscle Stimulation for Physical Function During Stem Cell Transplant

NAActive, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

May 13, 2026

Conditions
Autologous Hematopoietic Stem Cell Transplant
Interventions
DEVICE

RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA)

Active or Sham Neuromuscular electrical stimulation. US Food and Drug Administration-approved 2012

Trial Locations (1)

98108-1532

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

All Listed Sponsors
lead

VA Office of Research and Development

FED